By Howard Dean The drugmaker Teva Pharmaceuticals made history in June by launching the first-ever generic version of a GLP-1 diabetes drug. This revolutionary class of medications, which are also growing increasingly popular as treatments for obesity, has proven astoundingly effective in helping diabetes patients manage their condition. The launch is good for millions of […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
“March In” Is Not the Answer
By Howard Dean All Democrats and many Republicans are committed to making prescription drugs more affordable. There is one strategy that is likely to make things worse: overriding patents on drugs developed with the help of federally funded research. This “march-in” option is not a good idea. It hinges on the Bayh-Dole Act, a 40-year-old […]